Preliminary Study of Dengzhan Xixin Injection on Prevention and Intervention of Cardiovascular and Cerebrovascular System Disease of Older People Caused by Metabolic Disorder / 中国中医药信息杂志

ABSTRACT

Objective To observe the effect of Dengzhan Xixin injection on prevention and intervention of cardiovascular and cerebrovascular system disease of older people caused by metabolic disorder. Method A Group with metabolic syndrome were treated with a mixture of 30～40 mL of Dengzhan Xixin injection in 250 mL of physiological saline by intravenous injections (n=52). A treatment session was one injection once a day for 10～14 days. Each session was repeated every six months for a duration of three years. Cardiovascular and cerebrovascular disease symptoms, and changes of high sensitivity C-reactive protein (hsCRP) were measured compared with the control group (n=50). Results Compared to the control group, the intervention group had improved symptoms, lower occurrence of cardiovascular and cerebrovascular disease and ruduced hsCRP test result. The difference was significant (P